Engraftment of bone marrow progenitor cells in a rat model of asbestos-induced pulmonary fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 176, Issue 4, 2007, Pages 385-394

  Spees, Jeffrey L ^a,b   Pociask, Derek A ^a   Sullivan, Deborah E ^a   Whitney, Mandolin J ^a   Lasky, Joseph A ^a   Prockop, Darwin J ^a   Brody, Arnold R ^a,c  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Asbestosis; Bone marrow; Fibrosis; Progenitor cell

Indexed keywords

ASBESTOS; CHRYSOTILE; CYCLINE; GREEN FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASBESTOSIS; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; FLUORESCENCE IN SITU HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION;

ANIMALS; ASBESTOSIS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLASTS; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; IN SITU NICK-END LABELING; LUMINESCENT AGENTS; LUNG; MACROPHAGES, ALVEOLAR; MALE; MYOCYTES, SMOOTH MUSCLE; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34547948216     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200607-1004OC     Document Type: Article

References (35)

1. Morris G, Brody A. Molecular mechanisms of particle induced lung disease. In: Rom WN, editor. Environmental and occupational medicine, 3rd ed. Philadelphia: Lippincott-Raven; 1998. pp. 305-333
2. Chang LY, Overby LH, Brody AR, Crapo JD. Progressive lung cell reactions and extracellular matrix production after a brief exposure to asbestos. Am J Pathol 1988;131:156-170.
3. McGavran PD, Moore LM, Brody AR. Inhalation of chrysotile asbestos induces rapid cellular proliferation in small pulmonary vessels of mice and rats. Am J Pathol 1990;136:695-705.
4. Brody AR. Asbestos exposure as a model of inflammation inducing interstitial pulmonary fibrosis. In: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation: basic principles and clinical correlates, 2nd ed. New York: Raven Press; 1992. pp. 1033-1049
5. Lasky JA, Brody AR. Interstitial fibrosis and growth factors. Environ Health Perspect 2000;108:751-762.
6. Quinlan TR, Marsh JP, Janssen YM, Borm PA, Mossman BT. Oxygen radicals and asbestos-mediated disease. Environ Health Perspect 1994;102:107-110.
7. Brody AR, Hill LH, Adkins B Jr, O'Connor RW. Chrysotile asbestos inhalation in rats: deposition pattern and reaction of alveolar epithelium and pulmonary macrophages. Am Rev Respir Dis 1981;123:670-679.
8. McGavran PD, Butterick CJ, Brody AR. Tritiated thymidine incorporation and the development of an interstitial lesion in the bronchiolaralveolar regions of the lungs of normal and complement-deficient mice after inhalation of chrysotile asbestos. J Environ Pathol Toxicol Oncol 1989;9:377-391.
9. Pinkerton KE, Plopper CG, Merler RR, Brody AR, Crapo JD. Airway branching patterns dictate asbestos fiber location and the extent of tissue injury at the alveolar level. Lab Invest 1986;55:688-695.
10. Mossman BT, Marsh JP, Sesko A, Hill S, Shatos MA, Doherty J, Petruska J, Adler KB, Hemenway D, Mickey R, et al. Inhibition of lung injury, inflammation, and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am Rev Respir Dis 1990;141:1266-1271.
11. Liu J-Y, Brass DM, Hoyle GW, Brody AR. TNF-α receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos fibers. Am J Pathol 1998;153:1839-1847.
12. Lasky JA, Ortiz LA. Antifibrotic therapy for the treatment of pulmonary fibrosis. Am J Med Sci 2001;322:213-221.
13. Prockop DJ, Gregory CA, Spees JL. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci USA 2003;11917-11923.
14. Herzog EL, Chai L, Krause DS. Plasticity of marrow derived cells. Blood 2003;102:3483-3493.
15. Spees JL, Lasky JA, Pociask DA, Sullivan DE, Prockop DJ, Brody AR. Adult rat bone marrow cells migrate to normal and fibrogenic lungs and differentiate in various anatomic compartments [abstract]. 2004;:A212.
16. Brody AR, Pociask DA, Sullivan DE, Whitney MJ, Lasky JA, Prockop DJ, Spees JL. Bone marrow-derived cells migrate to the lung and differentiate in asbestos-induced fibroproliferative lesions [abstract]. 2005;:A282.
17. Ito T, Suzuki A, Imai E, Okabe M, Hori M. Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. J Am Soc Nephrol 2001;12:2625-2635.
18. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, editors. Current protocols in molecular biology. Hoboken, NJ: Wiley; 1998.
19. Warshamana GS, Corti M, Brody AR. TNF-alpha, PDGF, and TGF-beta(1) expression by primary mouse bronchiolar-alveolar epithelial and mesenchymal cells: TNF-alpha induces TGF-beta (1). Exp Mol Pathol 2001;71:13-33.
20. Brody AR, Overby LH. Incorporation of tritiated thymidine by epithelial and interstitial cells in bronchiolar-alveolar regions of asbestosexposed rats. Am J Pathol 1989;134:133-144.
21. Aljandali A, Pollack H, Yeldandi A, Li Y, Weitzman SA, Kamp DW. Asbestos causes apoptosis in alveolar epithelial cells: role of ironinduced free radicals. J Lab Clin Med 2001;137:330-339.
22. Kotton DN, Fabian AJ, Mulligan RC. Failure of bone marrow to reconstitute lung epithelium. Am J Respir Cell Mol Biol 2005;33:328-334.
23. Chang JC, Summer R, Sun X, Fitzsimmons K, Fine A. Evidence that bone marrow cells do not contribute to the alveolar epithelium. Am J Respir Cell Mol Biol 2005;33:335-342.
24. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S, Sharkis SJ. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001;105:369-377.
25. Loi R, Beckett T, Goncz KK, Suratt BT, Weiss DJ. Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells. Am J Respir Crit Care Med 2006;173:171-179.
26. Harris RG, Herzog EL, Bruscia EM, Grove JE, Van Arnam JS, Krause DS. Lack of fusion requirement for development of bone marrowderived epithelia. Science 2004;305:90-93.
27. Hashimoto N, Jin H, Chensue SW, Phan SH. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2003;113:243-252.
28. Perdue TD, Brody AR. Distribution of transforming growth factor-beta 1, fibronectin, and smooth muscle actin in asbestos-induced pulmonary fibrosis in rats. J Histochem Cytochem 1994;42:1061-1070.
29. Epperly MW, Guo H, Gretton JE, Greenberger JS. Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am J Respir Cell Mol Biol 2003;29:213-224.
30. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, Belperio JA, Keane MP, Strieter RM. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004;114:438-446.
31. McGavran PD, Butterick CJ, Brody AR. Tritiated thymidine incorporation and the development of an interstitial lesion in the bronchiolaralveolar regions of the lungs of normal and complement deficient mice after inhalation of chrysotile asbestos. J Environ Pathol Toxicol Oncol 1989;9:377-391.
32. Warheit DB, Hill LH, George G, Brody AR. Time course of chemotactic factor generation and the macrophage response to asbestos inhalation. Am Rev Respir Dis 1986;134:128-133.
33. Brody AR, Brass DM, Liu J-Y, Morris GF, Hoyle GW. Asbestosinduced peptide growth factors that mediate interstitial pulmonary fibrosis. In: Chiyotani K, Hosoda Y, Aizawa Y, editors. Advances in the prevention of occupational respiratory diseases. Amsterdam, The Netherlands: Elsevier Science; 1998. pp. 878-883.
34. Direkze NC, Forbes SJ, Brittan M, Hunt T, Jeffery R, Preston SL, Poulsom R, Hodivala-Dilke K, Alison MR, Wright NA. Multiple organ engraftment by bone marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice. Stem Cells 2003;21:514-520.
35. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003;100:8407-8411.